Zalypsis
[(1R,2S,13R,15S,16S)-15,22-dihydroxy-21-methoxy-6,20,24-trimethyl-13-[[[(E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl]amino]methyl]-8,10-dioxa-14,24-diazahexacyclo[14.7.1.02,14.04,12.07,11.018,23]tetracosa-4,6,11,18(23),19,21-hexaen-5-yl] acetate
Molecular Identity
Zalypsis
[(1R,2S,13R,15S,16S)-15,22-dihydroxy-21-methoxy-6,20,24-trimethyl-13-[[[(E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl]amino]methyl]-8,10-dioxa-14,24-diazahexacyclo[14.7.1.02,14.04,12.07,11.018,23]tetracosa-4,6,11,18(23),19,21-hexaen-5-yl] acetate
PubChem CID: 16061448
2D Structure
Properties
C37H38F3N3O8
Molecular Formula
709.70
Molecular Weight
g/mol
709.2611
Exact Mass
Da
5
XLogP
Above Lipinski threshold
130
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
13
H-Bond Acceptors
1320
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
ZalypsisPM00104308359-57-1PM-00104C21EZR41AY2-Propenamide, N-(((6aS,7R,13S,14S,16R)-5-(acetyloxy)-6,6a,7,13,14,16-hexahydro-8,14-dihydroxy-9-methoxy-4,10,17-trimethyl-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocin-16-yl)methyl)-3-(3-(trifluoromethyl)phenyl)-, (2E)-DTXSID0044026[(1R,2S,13R,15S,16S)-15,22-dihydroxy-21-methoxy-6,20,24-trimethyl-13-[[[(E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl]amino]methyl]-8,10-dioxa-14,24-diazahexacyclo[14.7.1.02,14.04,12.07,11.018,23]tetracosa-4,6,11,18(23),19,21-hexaen-5-yl] acetate((1R,2S,13R,15S,16S)-15,22-dihydroxy-21-methoxy-6,20,24-trimethyl-13-((((E)-3-(3-(trifluoromethyl)phenyl)prop-2-enoyl)amino)methyl)-8,10-dioxa-14,24-diazahexacyclo(14.7.1.02,14.04,12.07,11.018,23)tetracosa-4,6,11,18(23),19,21-hexaen-5-yl) acetatePM 00104RefChem:174945Synthetic Alkaloid PM00104DTXCID8024026UNII-C21EZR41AYorb1698932
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Zalypsis
Loading drug network...